Industry
Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
March 11, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
March 06, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
February 12, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
August 09, 2023 | 4:27 pm
Portfolio Pulse from Benzinga Insights
June 05, 2023 | 5:31 pm
Portfolio Pulse from Lisa Levin
June 05, 2023 | 5:09 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.